Seegnal Inc. (FRA:2I1)

Germany · Delayed Price · Currency is EUR

0.0973

+0.0005 (0.52%)

Last updated: Oct 23, 2026, 8:01 AM CEST

Market Cap	5.86M
Revenue (ttm)	1.19M +7.3%
Net Income	-5.58M
EPS	-0.15
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0973
Previous Close	0.0968
Day's Range	0.0973 - 0.0973
52-Week Range	0.0955 - 0.1456
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 1, 2026

About Seegnal

Seegnal Inc. provides SaaS clinical division support solutions. Its clinical decision support platform designed to empower clinicians in managing and resolving patient-specific drug-related problems. Its platform integrates with electronic medical records or other relevant systems that gather an array of applicable data into a patented interface, as well as clinicians gain instant access to vital information, enabling to make informed decisions at the point of care. The company is based in Calgary, Canada. [Read more]

Industry Health Information Services

Sector Healthcare

CEO Elad Bibi-Aviv

Employees 12

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol 2I1

Financial Performance

In 2025, Seegnal's revenue was $1.26 million, a decrease of -7.47% compared to the previous year's $1.37 million. Losses were -$6.21 million, 621.9% more than in 2024.

Financial numbers in USD Financial Statements